Severity of the autoimmune encephalomyelitis symptoms in mouse model by inhibition of LAT-1 transporters
- 14 December 2019
- journal article
- research article
- Published by Springer Nature in Journal of Pharmaceutical Investigation
- Vol. 50 (5) , 481-491
Abstract
No abstract availableKeywords
Funding Information
- Korea Research Institute of Standards and Science (2G10460, 2G10080)
This publication has 41 references indexed in Scilit:
- Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiationNature Immunology, 2013
- Persistent Inflammation in the CNS during Chronic EAE Despite Local Absence of IL-17 ProductionMediators of Inflammation, 2013
- Expression and activation of matrix metalloproteinase-9 and NADPH oxidase in tissues and plasma of experimental autoimmune encephalomyelitis in miceExperimental and Toxicologic Pathology, 2012
- Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disordersNeuroscience, 2010
- Glutamine Uptake and Metabolism Are Coordinately Regulated by ERK/MAPK during T Lymphocyte ActivationThe Journal of Immunology, 2010
- Role of the l-amino Acid Transporter-1 (LAT-1) in Mouse Trophoblast Cell InvasionPlacenta, 2010
- IL-12– and IL-23–modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibitionJournal of Experimental Medicine, 2008
- Human IL4I1 is a secreted l-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferationBlood, 2007
- Alanine metabolism, transport, and cycling in the brainJournal of Neurochemistry, 2007
- The Complementary Membranes Forming the Blood‐Brain BarrierIUBMB Life, 2002